Exact Sciences Completes 54,000 Cologuard Tests during the Second Quarter

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. GOOGL
9. RTX
10. S

Go back to Exact Sciences Completes 54,000 Cologuard Tests during the Second Quarter

Exact Sciences (EXAS) PT Raised to $20 at Jefferies

July 27, 2016 8:38 AM EDT

Jefferies analyst Brandon Couillard reiterated a Buy rating and raised his price target on Exact Sciences (NASDAQ: EXAS) to $20.00 (from $13.00) following strong Q2 results.

Couillard commented, "EXAS delivered an exceptionally strong 2Q that exhibited positive progress on essentially every key... More

Exact Sciences (EXAS) Tops Q2 EPS by 9c

July 26, 2016 6:20 AM EDT

Exact Sciences (NASDAQ: EXAS) reported Q2 EPS of ($0.46), $0.09 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $21.2 million versus the consensus estimate of $18.54 million.

For earnings history and earnings-related data on Exact Sciences (EXAS) click here.

... More